Severity of depressive and motor symptoms. Parkinson's disease
Conditions
Interventions
Intervention 1: Control group: routine Parkinson's disease drug with the dose specified by the doctor + placebo capsule twice a day. Intervention 2: Intervention group: routine Parkinson's disease dru
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age 30-75 Diagnosis for Parkinson's disease by Neurologist Diagnosis of depression, mild to moderate according to HAM-D
Exclusion criteria
Exclusion criteria: Age outside the range of 30-75 years Diagnosis or history of other neurological diseases such as epilepsy and Alzheimer's disease Diagnosis or history of vascular disorders, dementia and stroke Diagnosis or history of other psychiatric disorders such as bipolar disorder Addiction Antipsychotic use in the past year Diagnosis of central nervous system infections such as meningitis during the study Use of Linezolid at the beginning of the study, or during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of depressive and motor symptoms. Timepoint: Weeks 0 - 4 - 8. Method of measurement: By Hamiltion Depression Rating Scale & MDS-UPDRS III. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Shahin Akhondzadeh
Tehran University of Medical Sciences
Outcome results
None listed